A review of the Chido/Rodgers blood group

Immunohematology

Volumn 26, Issue 1, 2010, Pages 30-38

  Mougey, R ^a  

^a Mougey Incorporated   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CELL ANTIBODY; CHIDO ANTIBODY; COMPLEMENT COMPONENT C4; RODGERS ANTIBODY; UNCLASSIFIED DRUG; BLOOD GROUP ANTIGEN; COMPLEMENT COMPONENT C4A; COMPLEMENT COMPONENT C4B;

ANTIBODY PRODUCTION; BIOCHEMISTRY; BLOOD BANK; BLOOD GROUP SYSTEM; BLOOD GROUP TYPING; DISEASE ASSOCIATION; ERYTHROCYTE; GENETICS; HLA SYSTEM; HUMAN; LEUKOCYTE; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; SERODIAGNOSIS; SEROLOGY; AUTOIMMUNE DISEASE; BLOOD; BLOOD GROUP INCOMPATIBILITY; BLOOD TRANSFUSION; CHEMISTRY; CHROMOSOME 6; COMPLEMENT ACTIVATION; ETHNIC GROUP; GENETIC POLYMORPHISM; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; ISOLATION AND PURIFICATION; MAJOR HISTOCOMPATIBILITY COMPLEX; STANDARDS; STRUCTURE ACTIVITY RELATION;

AUTOIMMUNE DISEASES; BLOOD BANKS; BLOOD GROUP ANTIGENS; BLOOD GROUP INCOMPATIBILITY; BLOOD TRANSFUSION; CHROMOSOMES, HUMAN, PAIR 6; COMPLEMENT ACTIVATION; COMPLEMENT C4A; COMPLEMENT C4B; ETHNIC GROUPS; HUMANS; MAJOR HISTOCOMPATIBILITY COMPLEX; POLYMORPHISM, GENETIC; SELF TOLERANCE; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 77956569656     PISSN: 0894203X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (75)

1. Harris JP, Tegoli J, Swanson J, Fisher N, Gavin J, Noades J. A nebulous antibody responsible for crossmatching difficulties (Chido). Vox Sang 1967;12:140-2.
2. a specificity are white cell antibodies (abstract). Fed Proc 1971;30:248.
3. Middleton J, Crookston MC. Chido substance in plasma. Vox Sang 1972;23:256-61.
4. Swanson JL. Laboratory problems associated with leukocyte antibodies. In: Seminar on recent advances in immunohematology. Washington, DC: American Association of Blood Banks.1973 121-55.
5. Middleton J, Crookston MC, Falk JA, et al. Linkage of Chido and HLA. Tissue Antigen 1974;4:366-73.
6. a, reacting with red cell and serum antigen. Vox Sang 1976;30:175-80.
7. a. J Immunogenet 1980;7:301-6.
8. Giles CM. A new genetic variant for Chido. Vox Sang 1984;46:149-56.
9. a (Rodgers) and the HLA region: linkage and association. Tissue Antigens 1976;8:143-49.
10. James J, Stiles P, Boyce F, Wright J. The HL-A type of Rg(a-) individuals. Vox Sang 1976;30:214-16.
11. O'Neill GJ, Yang SY, Tegoli J, Berger R, Dupont B. Chido and Rodgers blood groups are distinct antigen components of human complement C4. Nature 1978;273:668-70.
12. Tilley CA, Romans DG, Crookston MC. Localization of Chido and Rodgers determinants to the C4d fragment of human C4. Nature 1978;273:713-5.
13. Judd WJ, Kraemer K, Moulds JJ. The rapid identification of Chido and Rodgers antibodies using C4d coated red blood cells. Transfusion 1981;21:189-92.
14. Giles CM, Hoffman M, Moulds M, Harris M, Delmasso A. Allo anti-Chido in a Ch-positive patient. Vox Sang 1987;52:129-33.
15. Moulds JM, Nickells MW, Moulds JJ, et al. The C3b/C4b receptor is recognized by the Knops, McCoy, Swain-Langley, and York blood group sera. J Exp Med 1991;173:1159-63.
16. Rao N, Ferguson DJ, Lee SF, Telen MJ. Identification of human erythrocyte blood group antigens of C3b/C4b receptor. J Immunol 1991;146:3501-7.
17. Lambin P, LePennec PY, Hauptmann G, et al. Adverse transfusion reactions associated with a precipitating anti-C4 antibody of anti-Rodgers specificity. Vox Sang 1984;47:242-9.
18. Westhoff CM, Sipherd BD, Wylie DE, Toalson LD. Severe anaphylactic reactions following transfusions of platelets to a patient with anti-Ch. Transfusion 1992;32:576-9.
19. Strupp A, Cash K, Uehlinger J. Difficulties in identifying antibodies in the Dombrock blood group system in multiply alloimmunized patients, Transfusion 1998;38:1022-5.
20. Awdeh ZL, Alper CA. Inherited structural polymorphism of the fourth component of human complement. Proc Natl Acad Sci U S A 1980;77:3576-80.
21. Rittner C, Giles CM, Roos MH, Demant P, Mollenhauer E. Genetics of human C4 polymorphism: detection and segregation of rare and duplicated haplotypes. Immunogenetics 1984;19:321-33.
22. Roos MH, Giles CM, Demant P, Mollenhuuer E, Rittner C. Rodgers (Rg) and Chido (Ch) determinants on human C4: characterization of two C4B5 subtypes, one of which contains Rg and Ch determinants. J Immunol 1984;133:2634-40.
23. Yu CY. The complete exon-intron structure of a human complement component C4A gene. DNA sequences, polymorphisms and linkage to 21-hydroxylase gene. J Immunol 1991;146:1057-66.
24. Yu CY, Campbell RD, Porter RR. A structural model for the location of the Rodgers and Chido antigenic determinants and their correlation with the human complement components C4A/C4B isotypes. J Immunogenet 1988;27:399-405.
25. Belt KT, Carroll MC, Porter RR. The structural basis of the multiple forms of human complement component C4. Cell 1984;36:907-14.
26. Blanchong CA, Chung EK, Rupert KL, et al. Genetic, structural and functional diversities of human complement components C4A and C4B and their mouse homologues Slp and C4. Int Immunopharmacol 2001;1:365-92.
27. Law SK, Lichtenberg NA, Levine RP. Covalent binding and hemolytic activity of complement proteins. Proc Natl Acad Sci U S A 1980;77:7194-8.
28. Dodds AW, Ren X-D, Willis AC, Law SKA. The reaction mechanism of the internal thioester in the human complement component C4. Nature 1996;379:177-9.
29. Carroll MC, Fathallah DM, Bergamaschini L, Alicot EM, Isenman DE. Substitution of a single amino acid (aspartic acid for histidine) converts the functional activity of human complement C4B to C4A. Proc Natl Acad Sci U S A 1990;87:6868-72.
30. Colton HR. Genetics and synthesis of components of the complement system. In: Ross GD, ed. Immunobiology of the complement system. An introduction for research and clinical medicine. New York: Academic Press, 1986:174-6.
31. Uko G, Christiansen FT Dawkins RL, McCann VJ. Reference ranges for serum C4 concentrations in subjects with and without C4 null alleles. J Clin Pathol 1986;39:573-6.
32. Moulds JM, Arnett FC, Giles CM, Hamilton RG. A novel immunoassay for the quantification of human C4 gene products. Complement Inflamm 1990;7:93-101.
33. Chung EK, Yang Y, Rupert KL, et al. Determining the one, two, three, or four long and short loci human complement C4 in a major histocompatibility complex haplotype encoding C4A or C4B proteins. Am J Hum Genet 2002;71:810-22.
34. Fukuoka Y, Zia HZ, Sanchez-Munoz LB, Dellinger AL, Escribano L, Schwartz B. Generation of anaphylatoxins by human β-tryptase form C3, C4, C5. J Immunol 2008;180:6307-16.
35. Richani K, Soto E, Romero R, et al. Normal pregnancy is characterized by systemic activation of the complement system. J Matern Fetal Neonate Med 2005;17:239-45.
36. Gigli I, Fugita T, Nussenzweig V. Modulation of the classical pathway C3 convertase by plasma proteins C4 binding protein and C3b inactivator. Proc Natl Acad Sci U S A 1979;76:6596-600.
37. Gatenby PA, Barbosa JE, Lachmann PJ. Differences between C4A and C4B in the handling of immune complexes: the enhancement of CR1 binding is more important than the inhibition of immunoprecipitation. Clin Exp Immunol 1990;79:158-63.
38. Manderson AP, Pickering MC, Botto M, Walport MJ, Parrish CR. Continual low level activation of the classical complement pathway. J Exp Med 2001;194:747-56.
39. Giles CM. An update on Rodgers and Chido, the antigenic determinants of human C4. Immunohematology 1989;5:1-6.
40. Carroll MC, Palsdottir A, Belt KT, Porter RR. Deletion of complement C4 and 21-hydroxylase genes in the HLA class III region. EMBO J 1985;4:2547-52.
41. Mauff G, Alper CA, Dawkins RL, et al. C4 nomenclature statement. Complement Inflamm 1991;7:261-8.
42. Barba G, Rittner C, Schneider PM. Genetic basis of human complement C4A deficiency, detection of a point mutation leading to nonexpression. J Clin Invest 1993;91:1681-6.
43. Atkinson JP, Frank MM. Bypassing complement: evolutionary lessons and future implications. J Clin Invest 2006;116:1215-8.
44. Martinez OP, Longman-Jacobsen N, Davies R, et al. Genetics of human complement component C4 and evolution of the central MHC. Front Biosci 2001;6:D904-13.
45. Dangel AW, Mendoza AR, Baker BJ, et al. The dichotomous size variation of human complement C4 gene is mediated by a novel family of endogenous retroviruses which also establishes species-specific genomic patterns among Old World primates. Immunogenetics 1994;40:425-36.
46. Mack M, Bender K, Schneider PM. Detection of retroviral antisense transcripts and promoter activity of the HERV-K(C4) insertion in the MHC class III region. Immunogenetics 2004;56:321-32.
47. Yu CY, Campbell RD. Definitive RFLPS to distinguish between the human complement C4/C4B isotypes and the major Rodgers/Chido determinants: application to the study of C4null alleles. Immunogenetics 1987;25:383-90.
48. Yu CY, Yang Z, Blanchong CA, Miller W. The human and mouse MHC class III region: a parade of the centromeric segment with 21 genes. Immunol Today 2000;21:320-8.
49. Chung EK, Yang Y, Rupert KL, et al. Determining the one, two, three or four long and short loci of human complement C4 in a major histocompatibility complex haplotype encoding C4A or C4B proteins. Am J Hum Genet 2002;71:810-22.
50. Wu YL, Yang Y, Chung EK, et al. Phenotypes, genotypes and disease susceptibility associated with gene copy number variations: complement C4 CNVs in European American healthy subjects and those with systemic lupus erythematosus. Cytogenet Genome Res 2008;123:131-41.
51. Szilagyi A, Fust G. Diseases associated with low copy number of the C4B gene encoding C4, the fourth component of complement. Cytogenet Genome Res 2008;123:118-30.
52. Blanchong CA, Zhou B, Rupert KL, et al. Deficiencies of human complement component C4A and C4B and heterozygosity in length variants of RP-C4-CYP21-TNX (RCCX) modules in Caucasians: the load of RCCX genetic diversity on major histocompatibility complex-associated disease. J Exp Med 2000;191:2183-96.
53. Yang Y, Chung EK, Zhou B, et al. The intricate role of complement component C4 in human systemic lupus erythematosus. Curr Dir Autoimmun. 2004;7:98-132.
54. Harley IT, Kaufman KM, Langfeld CD, Harley JB, Kelly JA. Genetic susceptibility to lupus: new insights from fine mapping and genome-wide association studies. Nat Rev Genet 2009;10:285-90.
55. Crosslin KL, Wiginton KL. The impact of race and ethnicity on disease severity in systemic lupus erythematosus. Ethn Dis 2009;19:301-7.
56. Hiraki LT, Benseler SM, Tyrrell PN, Harvey E, Herbert D, Silverman ED. Ethnic differences in pediatric systemic lupus erythematosus. J Rheumatol 2009;36:2539-46.
57. Figueroa JE, Densen P. Infectious diseases associated with complement deficiencies. Clin Microbiol Rev 1991;4:359-95.
58. Shi J, Levinson DF, Duan J, et al. Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature 2009;460:753-7.
59. Mayilyan LR, Weinberger DR, Sim RB. The complement system in schizophrenia. Drug News Perspect 2008;21:200-10.
60. Sorensen B, Jones JF, Vernon SD, Rajeevan MS. Transcription control of complement activation in an exercise model of chronic fatigue syndrome. Mol Med 2009;15:34-42.
61. Sweeten TL, Odell DW, Odell JD, Torres AR. C4B null alleles are not associated with genetic polymorphisms in the adjacent gene CYP21A2 in autism. BMC Med Genet 2008;9:1-7.
62. Zhou J, Fonseca MI, Pisalyaput K, Tenner AJ. Complement C3 and C4 expression in C1q sufficient and deficient mouse models of Alzheimer's disease. J Neurochem 2008;106:2080-92.
63. Szilagyi A, Fust G. Diseases associated with the low copy number of the C4B gene encoding C4, the fourth component of complement. Cytogenet Genome Res 2008;123:118-30.
64. Arason GJ, Kramer J, Blasko B, et al. Smoking and a complement gene polymorphism interact in promoting cardiovascular disease morbidity and mortality. Clin Exp Immunol 2007;149:132-8.
65. Seppänen M, Suvilehto J, Lokki M-L, et al. Immunoglobulins and complement factor C4 in adult rhinosinusitis. Clin Exp Immunol 2006;145:219-27.
66. Arason GJ, Geirsson AJ, Kolka R, Vikingsdottir TH, Valdimarrson H. Deficiency of complement dependent prevention of immune precipitation in systemic sclerosis. Ann Rheum Dis 2002;61:257-60.
67. Lhotta K, Auinger M, Kronenberg F, Irsigler K, Konig P. Polymorphism of complement C4 and susceptibility to IDDM and microvascular complications. Diabetes Care 1996;19:53-5.
68. Ratanachaiyavong S, Demaine AG, Campbell RD, McGregore AM. Heat shock protein 70 (HS70) and complement C4 genotypes in patients with hyperthyroid Graves' disease. Clin Exp Immunol 1991;84:48-52.
69. Wyatt RJ, Julian BA, Woodford SY. C4A deficiency and poor prognosis in patients with IgA nephropathy. Clin Nephrol 1991;36:1-5.
70. Hillarby MC, Strachan T, Grennan DM. Molecular characterisation of C4 null alleles found in Felty's syndrome. Ann Rheum Dis 1990;49:763-7.
71. Wyatt RJ, Wang C, Hudson EC, et al. Complement phenotypes in patients with psoriasis. Hum Hered 1989;39:327-32.
72. Fielder AH, Ollier W Lord DK, et al. HLA class III haplotypes in multicase rheumatoid arthritis families. Hum Immunol 1989;25:75-85.
73. Robb SA, Fielder AHL, Saunders CEL. C4 complement allotypes in juvenile dermatomyositis. Hum Immunol 1988;22:31-8.
74. Briggs DC, Donaldson PT, Hayes P, et al. A major histocompatibility complex class III allotype (C4B2) associated with primary biliary cirrhosis (PBC). Tissue Antigens 1987;29:141-5.
75. McLean RH, Wyatt RJ, Julian BA. Complement phenotypes in glomerulonephritis. Increased frequency of homozygous null C4 phenotypes in IgA nephropathy and Henoch-Schönlein purpura. Kidney Int 1984;26:855-60.